CNSX:GTIIPharmaceuticals
How Green Thumb’s DEA Schedule III Registration Move Could Impact Green Thumb Industries (CNSX:GTII) Investors
Green Thumb Industries recently submitted applications to the U.S. Drug Enforcement Administration to register certain state-licensed medical cannabis operations under the new Schedule III pathway, following federal rescheduling of medical marijuana.
This move could expand federally regulated operations, support research access, and improve tax treatment, potentially enhancing the company’s operational flexibility and financial efficiency.
We’ll now explore how Green Thumb’s DEA registration...